Telaria, Inc. Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jun 30, 2016	Q1 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q3 FY2015 As of Sep 30, 2015	Q2 FY2015 As of Jun 30, 2015	Q1 FY2015 As of Mar 31, 2015
Assets
Current assets:
Cash and cash equivalents
Accounts receivable, net
Prepaid expenses and other current assets
Deferred tax assets, short-term
Current assets of discontinued operations
Total current assets

Long-term assets:
Deferred tax assets
Restricted cash
Operating lease right-of-use asset, net of amortization
Property and equipment, net
Intangible assets, net
Goodwill
Deferred tax asset
Other assets
Non-current assets of discontinued operations
Total long-term assets

Total assets
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued expenses
Operating lease liability, current portion
Deferred rent, current portion
Capital leases, short-term
Contingent consideration on acquisition
Deferred income
Other current liabilities
Current liabilities of discontinued operations
Total current liabilities
Long-term liabilities:
Operating lease liability, net of current portion
Deferred rent, net of current portion
Contingent consideration on acquisition
Capital leases
Deferred tax liabilities
Other liabilities

Non-current liabilities of discontinued operations
Total liabilities
Stockholders’ equity:
Common stock, $0.0001 par value: 250,000,000 shares authorized as of December 31, 2019 and 2018, respectively; 59,481,057 and 56,956,935 shares issued and 46,916,817 and 44,392,695 shares outstanding as of December 31, 2019 and 2018, respectively
Treasury stock, 12,564,240 shares at cost as of December 31, 2019 and 2018, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments